PMID:9744800

Caenorhabditis elegans small heat-shock proteins Hsp12.2 and Hsp12.3 form tetramers and have no chaperone-like activity.

Recombinant C. elegans HSP-12.2 and HSP-12.3 form tetramers, making them the first sHSPs shown to occur as tetramers. Both are devoid of in vitro chaperone-like abilities. These proteins have very short N-terminal regions and lack C-terminal tails. The authors conclude that higher multimer formation, mediated through N-terminal domains, is a prerequisite for chaperone-like activity.

"both appear devoid of in vitro chaperone-like abilities. This supports the notion that tetramers are the building blocks of sHSP complexes, and that higher multimer formation, mediated through the N-terminal domains, is a prerequisite for chaperone-like activity."

file:worm/hsp-12.3/hsp-12.3-deep-research-falcon.md

Falcon deep research report on hsp-12.3

HSP-12.3 is a minimal alpha-crystallin-domain sHSP encoded by ORF F38E11.1 (Ce12.3) with a markedly shortened N-terminus and little to no C-terminal tail, placing it in the Hsp12/sHSP group of the smallest known sHSPs.

"In *C. elegans*, Hsp-12 family proteins are described as **very small (~12 kDa)** proteins that retain the conserved **α-crystallin domain** but have **markedly shortened N-termini** and **little to no C-terminal tail**, i.e., a “minimal” sHSP architecture."
HSP-12.3 assembles as a tetramer and forms heterotetramers with HSP-12.2, consistent with partner-dependent assembly rather than the large polydisperse oligomers of canonical sHSPs.

"Unlike many sHSPs that form larger multimeric assemblies, HSP-12.3 is reported to assemble as a **tetramer**, and is additionally reported to form **heterotetramers with HSP-12.2**."
Recombinant HSP-12.3 did not prevent citrate synthase aggregation in a thermal unfolding assay, indicating no detectable classical holdase activity under those conditions, consistent with its highly truncated termini.

"Recombinant **HSP-12.3 did not prevent citrate synthase aggregation** in a thermal unfolding assay, indicating **no detectable classical holdase activity under those conditions**."
In an evolutionary study of sHSP-mediated sequestration, HSP-12.3 was classified as sequestrase-negative and lacked sequence features associated with sequestrase-positive sHSPs, arguing against a major role in inclusion-forming sequestration.

"HSP-12.3 was classified as sequestrase-negative and lacked sequence features associated with sequestrase-positive sHSPs, arguing against a major role in inclusion-forming sequestration."
hsp-12.3 is repeatedly described as a DAF-16/FOXO-associated insulin-signaling target, upregulated when daf-2/IIS is reduced and downregulated when daf-16 activity is reduced.

"it is reported as **upregulated when daf-2/IIS is reduced** and **downregulated when daf-16 activity is reduced**, consistent with hsp-12.3 being among downstream DAF-16-linked stress/longevity effector genes"
hsp-12.3 (F38E11.1) shows reduced expression in hpk-1 loss-of-function animals, linking it to HPK-1/DAF-16-dependent stress and aging regulation.

"**hsp-12.3 (F38E11.1)** is specifically noted among genes with **reduced expression** in **hpk-1 loss-of-function** animals (microarray Table S1 referenced in the paper)."
A 2024 whole-genome hypoxia study lists hsp-12.3 among stress-response genes positively regulated by HIF-1 under short-term hypoxia, though direct locus-level HIF-1 binding evidence was not confirmed in the excerpt.

"A 2024 genome-wide study of short-term hypoxia responses and HIF-1 binding reports **hsp-12.3** among **stress-response genes positively regulated by HIF-1 under short-term hypoxia**"
Deep quantitative proteomics identified HSP-12.3 among proteins that increase with age, with a greater increase in long-lived daf-2(e1370) mutants, indicating IIS-dependent proteostasis remodeling at the protein level.

"Deep quantitative proteomics identified **HSP-12.3 among proteins that increase with age**."
The most defensible current localization statement is that HSP-12.3 is a small cytosolic sHSP-family protein; precise compartment and tissue specificity remain to be confirmed with gene-specific reporters.

"the most defensible current statement is that **Hsp-12.3 is a small cytosolic sHSP-family protein**, but its precise subcellular compartment(s) and tissue specificity require confirmation with gene-specific reporters or specific antibodies."